PARP inhibitors in metastatic prostate cancer: Evidence to date

Emily Nizialek, Emmanuel S. Antonarakis

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'PARP inhibitors in metastatic prostate cancer: Evidence to date'. Together they form a unique fingerprint.

Medicine & Life Sciences